1-3 of 3
Mackenzie Malo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lintuzumab-Ac225 Exerts Mutation Agnostic Antileukemic Activity in Preclinical Models of AML

Amanda Chin, Rubin Jiao, Kevin J.H. Allen, Jason Li, Mary Chen, Madhuri Vusirikala, Avinash Desai, Le-Cun Xu, Patrik Brodin, Monideepa Roy, Mackenzie Malo, Denis Beckford-Vera, Ekaterina Dadachova, Helen Kotanides
Journal: Blood
Blood (2024) 144 (Supplement 1): 5801.
https://doi.org/10.1182/blood-2024-204282
Published: 2024
Journal Articles

Lintuzumab-Ac225, a CD33-Directed Antibody Radiotherapy, Targets AML in a Mutation Agnostic Manner

Amanda Chin, Rubin Jiao, Kevin J.H. Allen, Jason Li, Mary Chen, Madhuri Vusirikala, Le-Cun Xu, Patrik Brodin, Monideepa Roy, Mackenzie Malo, William Van der Touw, Ekaterina Dadachova, Denis Beckford-Vera, Helen Kotanides
Journal: Blood
Blood (2023) 142 (Supplement 1): 5750.
https://doi.org/10.1182/blood-2023-187498
Published: 2023
Journal Articles

Actinium Labeled Daratumumab Demonstrates Enhanced Killing of Multiple Myeloma Cells over Naked Daratumumab

Mark S. Berger, MD, Keisha Thomas, PhD, Dadachova Ekaterina, PhD, Mackenzie Malo, M.Sc., Rubin Jiao, PhD, Kevin Allen, PhD, Colin Clarke
Journal: Blood
Blood (2017) 130 (Supplement 1): 4427.
https://doi.org/10.1182/blood.V130.Suppl_1.4427.4427
Published: 2017